Latest Tech News

Healthcare providers urge Congress to Replenish the HRSA Uninsured Relief Fund

Led by the American Clinical Laboratory Association (ACLA), over 60 public health organizations representing patients, health care professionals, hospitals, public health, laboratories, and diagnostic manufacturers have sent a letter urging the U.S. Congress to replenish the HRSA COVID-19 Uninsured Relief Fund.Click here to view the letter sent by the ACLA and others to Congressional leadership.The Health

By |2022-05-12T11:47:03-04:00May 12th, 2022|Categories: News|0 Comments

Expiration Dates and Usage Guidelines for COVID-19 Kits

Throughout the pandemic, Aculabs has worked to meet the demand for ample COVID-19 specimen collection kits. Adequate access to such supplies remains highly important for physicians in catching COVID-19 early on in vulnerable populations. Clients who have received COVID-19 collection kits from Aculabs should continue using the kits provided, even tubes that display a

By |2022-06-17T17:28:36-04:00April 28th, 2022|Categories: News|0 Comments

Aculabs rolls out updates to Online Order web portal tools

The start of 2022 saw Aculabs roll out several new features to our online web portal, including Email Reporting for Result Notification and improved logic used in our Exception Test Flagging feature. The purpose of such features is to continue expanding the ways in which Aculabs communicates with your staff while tackling patient care

By |2022-04-21T15:41:35-04:00April 21st, 2022|Categories: News|0 Comments

QuantiFERON-TB Gold Plus now performed as in-house testing

Aculabs will be offering QuantiFERON-TB Gold Plus in-house as of April 6, 2022; the test provides highly accurate and reproducible results, single-step testing, and innovative CD8 T cell technology that provides a more comprehensive view of the immune response to TB infection. Letter from the Director: QuantiFERON-TB Gold Plus testing offers accuracy in health

By |2022-04-21T15:41:04-04:00April 14th, 2022|Categories: News|0 Comments

Supply Shortage on Grey & Pink Para-Paks to Impact Testing

Please be aware that several send-out tests will be temporarily unavailable to order, as supply shortages impacting the grey and pink parapak kits used for the collection of stool specimen have impacted the reference laboratories in which Aculabs utilizes for such send-out testing. The following are the most commonly ordered tests to be impacted:

By |2022-04-21T15:29:58-04:00March 17th, 2022|Categories: News|0 Comments

New Updates to Aculabs Online Order Entry System

As an industry leader, Aculabs values the way in which our digital and technological systems can always be improved to continually optimize the user experience. Our Online Web Portal remains the main hub for which many clients can 1) most easily place orders and 2) receive order results in the shortest time possible, necessary

By |2022-01-06T12:36:54-05:00January 6th, 2022|Categories: News|0 Comments

FDA Warns of Reduced Sensitivity for Omicron in Rapid Tests

In a new memo, the United States Food & Drug Administration (FDA) has documented and warned both patients and healthcare providers of the risk of Omicron, the latest variant of SARS-CoV-2, displaying reduced sensitivity to rapid antigen tests. Rapid antigen tests, sometimes referred to as lateral flow tests, are often used in occupational and

By |2021-12-29T11:19:27-05:00December 29th, 2021|Categories: News|0 Comments

COVID-19 Vaccine Mandate for HCW on Hold Nationwide

What is the status of the CMS Vaccine Mandate at present? The United States District Court in the Western District of Louisiana has issued a nationwide injunction preventing the federal government from implementing the CMS vaccine mandate for health care staff. This injunction applies to all states which were not covered by the injunction issued yesterday in ten states,

By |2021-12-29T15:03:50-05:00December 1st, 2021|Categories: News|Comments Off on COVID-19 Vaccine Mandate for HCW on Hold Nationwide

As cases soar, a new COVID-19 variant emerges: Omicron

Currently, the B16172 (Delta) variant, the B117 (Alpha) variant, the P1 (Gamma), and B1526 (NY variant) have been reported in New Jersey, but make way for the new one B.1.1.529 also known as Omicron - named for the 15th letter of the greek alphabet. This past Sunday, the WHO said it is not yet clear

By |2021-12-29T14:54:50-05:00November 29th, 2021|Categories: News|Comments Off on As cases soar, a new COVID-19 variant emerges: Omicron

CDC Warns of Supply Shortage for COVID-19 Rapid Tests

In a recent newsletter announcement, the Centers for Disease Control and Prevention warned of a shortage occurring for COVID-19 rapid tests. In this advisory, the CDC advised diagnostic service providers to expect an increase in the demand for laboratory-based COVID-19 testing due to a shortage in supply for both point-of-care testing and rapid testing

By |2021-10-29T12:54:39-04:00September 2nd, 2021|Categories: News|0 Comments
Go to Top